#cancer

Mayo Clinic researchers report that an immune-signal blood test identified most germ cell tumors in a study sample, including many cases missed by standard markers.

A Rutgers study points to senescent CD8+ T cells as a key reason some CAR T treatments fail, suggesting that the quality of the starting immune cells may shape whether the therapy can expand, persist, and work.

Researchers report a way to use engineered red blood cells to ferry mRNA into the body and reprogram myeloid immune cells to attack tumors, pointing to a potential alternative to conventional CAR cell manufacturing.

Scientists report the strongest evidence yet that Barrett’s esophagus is the starting point for esophageal adenocarcinoma, sharpening the case for earlier detection and surveillance.

A randomized phase 2 trial in Nature Medicine found that adding elraglusib to gemcitabine plus nab-paclitaxel improved median overall survival and one-year survival in previously untreated metastatic pancreatic ductal ad

Cancer rates in Canada are projected to remain high in 2026, with 254,100 cases expected and lung, breast, prostate, and colorectal cancers accounting for nearly half of new diagnoses.

A population-based study from Karolinska Institutet, published in BMJ Oncology, found that anemia detected in health care was associated with both a higher risk of cancer and higher mortality in adults.

A Northwestern Medicine study found that AI models produced more complete summaries of complex cancer pathology reports than physicians, highlighting a potentially important support role for generative systems in high-st

A new paper in Nature Health reports a strong link between environmental exposure to agricultural pesticides and cancer risk, combining environmental data with a national-level analytical approach to explore underlying机制

A small phase 1 study in relapsed or refractory multiple myeloma reports that anti-BCMA CAR-T cells can be generated inside the body after a single infusion, potentially bypassing several steps that usually slow access.